Evaluating cognitive profiles of patients undergoing clinical amyloid-PET imaging

Episodic memory impairment and brain amyloid-beta are two of the main hallmarks of Alzheimer’s Disease. In the clinical setting, these are often evaluated through neuropsychological testing and amyloid PET imaging, respectively. The use of amyloid PET in clinical practice is only indicated in patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Loreto, Flavia, Gunning, Stephen, Golemme, Mara, Watt, Hilary, Patel, Neva, Win, Zarni, Carswell, Christopher, Perry, Richard J, Malhotra, Paresh A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244634/
https://www.ncbi.nlm.nih.gov/pubmed/34222867
http://dx.doi.org/10.1093/braincomms/fcab035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244634/
https://www.ncbi.nlm.nih.gov/pubmed/34222867
http://dx.doi.org/10.1093/braincomms/fcab035

Ejemplares similares